PERCUTANEOUS CORONARY INTERVENTION
Clinical trials for PERCUTANEOUS CORONARY INTERVENTION explained in plain language.
Never miss a new study
Get alerted when new PERCUTANEOUS CORONARY INTERVENTION trials appear
Sign up with your email to follow new studies for PERCUTANEOUS CORONARY INTERVENTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart stent patients: could a tailored blood thinner dose reduce risks?
Disease control Recruiting nowThis study looks for the safest and most effective dose of blood thinners (P2Y12 inhibitors) for people who have had a heart stent placed. About 355 participants will try different doses to find one that keeps blood clotting at a healthy level—not too high (which can cause clots)…
Matched conditions: PERCUTANEOUS CORONARY INTERVENTION
Phase: PHASE3 • Sponsor: Cardiocentro Ticino • Aim: Disease control
Last updated May 17, 2026 07:03 UTC
-
Timing of blood thinner may prevent artery blockage after heart procedure
Disease control Recruiting nowThis study tests whether giving the blood thinner heparin before inserting a tube into the wrist artery can prevent blockage of that artery after a heart procedure. About 550 adults having a heart procedure through the wrist will be randomly assigned to get heparin either before …
Matched conditions: PERCUTANEOUS CORONARY INTERVENTION
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated May 17, 2026 06:48 UTC
-
New stomach drug could match standard care for heart patients at bleeding risk
Disease control Recruiting nowThis study compares a new stomach acid reducer (tegoprazan) with a standard one (rabeprazole) in about 3,320 heart patients who take blood thinners and are at high risk for stomach bleeding or ulcers. The goal is to see if the new drug works just as well at preventing serious sto…
Matched conditions: PERCUTANEOUS CORONARY INTERVENTION
Phase: PHASE4 • Sponsor: Duk-Woo Park, MD • Aim: Disease control
Last updated May 17, 2026 06:47 UTC
-
Arm cuff trick may shield heart failure patients from kidney damage during surgery
Disease control Recruiting nowThis study tests if briefly inflating a blood pressure cuff on the arm before a heart procedure can protect the kidneys and heart in people with heart failure. About 240 adults with heart failure who need a heart catheterization will be randomly assigned to receive either the cuf…
Matched conditions: PERCUTANEOUS CORONARY INTERVENTION
Phase: PHASE2, PHASE3 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Heart artery balloon showdown: which drug works best for Medium-Small vessels?
Disease control Recruiting nowThis study compares two types of drug-coated balloons (Selution with sirolimus vs. SeQuent Please Neo with paclitaxel) to treat narrowed heart arteries in medium-small vessels. About 140 adults with stable angina or stabilized acute coronary syndrome will be enrolled. The main go…
Matched conditions: PERCUTANEOUS CORONARY INTERVENTION
Phase: NA • Sponsor: Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Heart patients: could a diabetes drug shield your kidneys from dye damage?
Disease control Recruiting nowThis study looks at whether SGLT2 inhibitors (a type of diabetes drug) can prevent acute kidney injury caused by contrast dye used during heart procedures like angiography or stenting. Researchers will analyze data from 4,000 patients to compare kidney function before and after t…
Matched conditions: PERCUTANEOUS CORONARY INTERVENTION
Sponsor: Collegium Medicum w Bydgoszczy • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Can a natural supplement boost heart drug effects?
Disease control Recruiting nowThis study looks at whether berberine, a natural compound, can help blood thinners work better in people who have had a heart stent placed. About 64 adults who are already taking aspirin and clopidogrel will receive different doses of berberine or no extra treatment. The goal is …
Matched conditions: PERCUTANEOUS CORONARY INTERVENTION
Phase: PHASE4 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Smart algorithm could cut bleeding and clot risks after stent surgery
Disease control Recruiting nowThis study tests whether a personalized risk-score algorithm can better determine how long patients should take two blood thinners after getting a heart stent. About 2,788 adults receiving a drug-coated stent will be assigned to either algorithm-guided or standard treatment durat…
Matched conditions: PERCUTANEOUS CORONARY INTERVENTION
Phase: NA • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
New heart pump aims to make risky angioplasty safer
Disease control Recruiting nowThis study tests a temporary heart pump called iVAC 2L in 100 people with severe coronary artery disease who need high-risk angioplasty. The pump helps the heart keep pumping blood during the procedure. Researchers will track deaths, heart attacks, and strokes for one year to see…
Matched conditions: PERCUTANEOUS CORONARY INTERVENTION
Phase: NA • Sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation • Aim: Disease control
Last updated May 05, 2026 11:55 UTC
-
New heart test could replace painful procedure
Diagnosis Recruiting nowThis study tests a new technology called IVUS-FFR that uses ultrasound images from inside heart arteries to quickly check if a blockage is serious enough to need a stent. Unlike the current standard test, it doesn't require extra wires or medication that can cause discomfort. Abo…
Matched conditions: PERCUTANEOUS CORONARY INTERVENTION
Phase: NA • Sponsor: China National Center for Cardiovascular Diseases • Aim: Diagnosis
Last updated May 14, 2026 12:03 UTC
-
Twice-Yearly shot aims to shield heart and limbs after artery surgery
Prevention Recruiting nowThis study tests whether inclisiran, a twice-yearly injection that lowers bad cholesterol, can prevent major heart and limb events in 6,000 adults who recently had artery-opening procedures. Participants receive either inclisiran or a placebo, and researchers track heart attacks,…
Matched conditions: PERCUTANEOUS CORONARY INTERVENTION
Phase: PHASE4 • Sponsor: Duke University • Aim: Prevention
Last updated May 15, 2026 11:53 UTC
-
Nerve block may take the ouch out of heart catheterization
Symptom relief Recruiting nowThis study tests whether a numbing injection called a TAP block can reduce pain and improve satisfaction for 100 adults undergoing heart procedures like angiography or stenting through the groin. The block targets nerves that supply the groin area. Researchers will measure pain s…
Matched conditions: PERCUTANEOUS CORONARY INTERVENTION
Phase: NA • Sponsor: Istanbul University - Cerrahpasa • Aim: Symptom relief
Last updated May 17, 2026 06:47 UTC
-
Heart artery showdown: which technique wins?
Knowledge-focused Recruiting nowThis study compares two ways to open completely blocked heart arteries (chronic total occlusions) in 74 patients. One method works from the front of the blockage, the other from behind. Researchers will measure which is faster, safer, and less stressful for doctors.
Matched conditions: PERCUTANEOUS CORONARY INTERVENTION
Phase: NA • Sponsor: National Institute of Cardiology, Warsaw, Poland • Aim: Knowledge-focused
Last updated May 17, 2026 07:00 UTC
-
ICU study aims to shorten bed rest after heart procedures
Knowledge-focused Recruiting nowThis study looks at why some ICU patients bleed longer after a tube is removed from an artery in the groin following heart procedures. Researchers will track 157 adults to find factors that affect how long it takes to stop bleeding and how long patients must lie flat. The goal is…
Matched conditions: PERCUTANEOUS CORONARY INTERVENTION
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 06:46 UTC
-
Heart patients asked: would you risk death to avoid a metal stent?
Knowledge-focused Recruiting nowThis study asks 600 heart patients and their doctors which treatment they prefer for blocked arteries: a permanent metal stent or a drug-coated balloon that dissolves over time. The goal is to understand how much extra risk people are willing to accept to avoid having a metal imp…
Matched conditions: PERCUTANEOUS CORONARY INTERVENTION
Sponsor: Xijing Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 06:46 UTC
-
Polish heart registry aims to improve blocked artery treatments
Knowledge-focused Recruiting nowThis study is a registry that will collect information from 1,000 people in Poland who are having a procedure to open a completely blocked heart artery (called CTO PCI) as part of their normal care. The goal is to see how safe and effective these procedures are in everyday practi…
Matched conditions: PERCUTANEOUS CORONARY INTERVENTION
Sponsor: National Institute of Cardiology, Warsaw, Poland • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
Massive study aims to uncover hidden links between heart and kidney disease
Knowledge-focused Recruiting nowThis study is a large registry that will collect health information from up to 60,000 patients with both heart and kidney disease. The goal is to better understand how these conditions interact and what factors affect patient outcomes. No new treatments are being tested; instead,…
Matched conditions: PERCUTANEOUS CORONARY INTERVENTION
Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
Heart patients and doctors rank what matters most in clinical trials
Knowledge-focused Recruiting nowThis study compares how heart disease patients and healthcare providers weigh the importance of different health events, like heart attack or stroke, compared to death. Researchers want to see if patients and doctors value these events differently, which could help design better …
Matched conditions: PERCUTANEOUS CORONARY INTERVENTION
Sponsor: Xijing Hospital • Aim: Knowledge-focused
Last updated May 06, 2026 16:13 UTC